Tags : Leidos

Leidos Collaborates with GeoVax for the Development of Immunotherapies for

Shots: The companies will jointly develop vaccine candidates using Leidos’ PD-1 checkpoint inhibitors combined with GeoVax’s MVA-VLP vaccine platform GeoVax will design, construct, and characterize the developed product and further analysis will be done by Leidos GeoVax’s Modified Vaccinia Ankara (MVA) platform is used for developing in-vivo vaccines in the form of multimeric proteins or […]Read More